These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37498617)

  • 1. Exploring Olfactory Dysfunction as a Marker of Frailty and Postoperative Outcomes in Head and Neck Cancer.
    Mady LJ; De Ravin E; Vohra V; Lu J; Newman JG; Hall DE; Dalton PH; Rowan NR
    JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):828-836. PubMed ID: 37498617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic.
    Liu DT; Prem B; Besser G; Renner B; Mueller CA
    Am J Rhinol Allergy; 2022 Mar; 36(2):253-260. PubMed ID: 34704454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of olfactory dysfunction detected in treatment-naive patients with head and neck cancer.
    Barbosa da Silva JL; Anzolin LK; Nicacio SP; Doty RL; Pinna FR; Voegels RL; Fornazieri MA
    Acta Otolaryngol; 2023 Feb; 143(2):201-204. PubMed ID: 36861186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-perceived Taste and Flavor Perception: Associations With Quality of Life in Patients With Olfactory Loss.
    Liu DT; Besser G; Prem B; Sharma G; Speth MM; Sedaghat AR; Mueller CA
    Otolaryngol Head Neck Surg; 2021 Jun; 164(6):1330-1336. PubMed ID: 33048605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stellate Ganglion Block for the Treatment of COVID-19-Induced Olfactory Dysfunction: A Prospective Pilot Study.
    Peterson AM; Miller BJ; Kallogjeri D; Piccirillo JF; Kukuljan S; Roland LT; Schneider JS; Crock LW; Farrell NF
    Otolaryngol Head Neck Surg; 2024 Jan; 170(1):272-276. PubMed ID: 37750244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory Function After Surgical Treatment of CRS: A Comparison of CRS Patients to Healthy Controls.
    Mattos JL; Soler ZM; Schlosser RJ; Mace JC; Alt JA; Ramakrishnan VR; Payne SC; Smith TL; Beswick DM
    Am J Rhinol Allergy; 2021 May; 35(3):391-398. PubMed ID: 32954837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the relationship between olfactory-specific quality of life, objective olfactory loss, and patient factors in chronic rhinosinusitis.
    Mattos JL; Schlosser RJ; Storck KA; Soler ZM
    Int Forum Allergy Rhinol; 2017 Jul; 7(7):734-740. PubMed ID: 28519966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19.
    Boscolo-Rizzo P; Menegaldo A; Fabbris C; Spinato G; Borsetto D; Vaira LA; Calvanese L; Pettorelli A; Sonego M; Frezza D; Bertolin A; Cestaro W; Rigoli R; D'Alessandro A; Tirelli G; Da Mosto MC; Menini A; Polesel J; Hopkins C
    Chem Senses; 2021 Jan; 46():. PubMed ID: 33575808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Combined Visual-Olfactory Training With Patient-Preferred Scents as Treatment for Patients With COVID-19 Resultant Olfactory Loss: A Randomized Clinical Trial.
    Khan AM; Piccirillo J; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2023 Feb; 149(2):141-149. PubMed ID: 36580304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression Symptoms and Olfactory-related Quality of Life.
    Liu DT; Prem B; Sharma G; Kaiser J; Besser G; Mueller CA
    Laryngoscope; 2022 Sep; 132(9):1829-1834. PubMed ID: 35353380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Taste and Smell Outcomes After COVID-19.
    Sharetts R; Moein ST; Khan R; Doty RL
    JAMA Netw Open; 2024 Apr; 7(4):e247818. PubMed ID: 38652477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Novel At-home Smell Assessment.
    Gupta S; Kallogjeri D; Farrell NF; Lee JJ; Smith HJ; Khan AM; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2022 Mar; 148(3):252-258. PubMed ID: 35024772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.
    Speth MM; Singer-Cornelius T; Oberle M; Gengler I; Brockmeier SJ; Sedaghat AR
    Otolaryngol Head Neck Surg; 2020 Jul; 163(1):114-120. PubMed ID: 32423357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality-of-life and olfaction changes observed with short-term medical management of chronic rhinosinusitis.
    Thomas AJ; Mace JC; Ramakrishnan VR; Alt JA; Mattos JL; Schlosser RJ; Soler ZM; Smith TL
    Int Forum Allergy Rhinol; 2020 May; 10(5):656-664. PubMed ID: 32017433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural trajectory of recovery of COVID-19 associated olfactory loss.
    Khan AM; Lee J; Rammaha T; Gupta S; Smith H; Kannampallil T; Farrell N; Kallogjeri D; Piccirillo JF
    Am J Otolaryngol; 2022; 43(5):103572. PubMed ID: 35969913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Psychometric Validation of the Olfactory Dysfunction Outcomes Rating.
    Lee JJ; Mahadev A; Kallogjeri D; Peterson AM; Gupta S; Khan AM; Jiramongkolchai P; Schneider JS; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1132-1139. PubMed ID: 36264557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting olfactory dysfunction in COVID-19 patients.
    Prem B; Liu DT; Besser G; Sharma G; Dultinger LE; Hofer SV; Matiasczyk MM; Renner B; Mueller CA
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3485-3492. PubMed ID: 34757458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between olfactory subdomains and frailty: A prospective case‒control study investigation.
    Cheng MZ; Vohra V; Wang H; Katuri A; Langdon JM; Xue QL; Rowan NR
    Int Forum Allergy Rhinol; 2024 Oct; 14(10):1598-1606. PubMed ID: 38940232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smell dysfunction: a biomarker for COVID-19.
    Moein ST; Hashemian SM; Mansourafshar B; Khorram-Tousi A; Tabarsi P; Doty RL
    Int Forum Allergy Rhinol; 2020 Aug; 10(8):944-950. PubMed ID: 32301284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Saline Nasal Irrigation Plus Theophylline for Treatment of COVID-19-Related Olfactory Dysfunction: The SCENT2 Phase 2 Randomized Clinical Trial.
    Gupta S; Lee JJ; Perrin A; Khan A; Smith HJ; Farrell N; Kallogjeri D; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2022 Sep; 148(9):830-837. PubMed ID: 35797024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.